Table 2.
Prognostic factors affecting survival using the Cox proportional hazard model.
| p value | HR | 95% CI | |
|---|---|---|---|
|
| |||
| Age, years | 0.5567 | 1.0233 | 0.9477–1.1050 |
|
| |||
| Gender | |||
| • Female | • 0.3088 | • 1.7627 | • 0.5917–5.2513 |
|
| |||
| Anti-HCV | |||
| • Negative | • 0.0960 | • 2.3158 | • 0.8615–6.2246 |
|
| |||
| Cirrhosis | |||
| • No | • 0.0851 | • 0.2708 | • 0.0612–1.1.1981 |
|
| |||
| Grade of siderosis | |||
| • mild/moderate | • 0.9444 | • 1.0331 | • 0.4139–2.5783 |
|
| |||
| αFP levels | |||
| • >100 ng/ml | • 0.5519 | • 0.7812 | • 0.1659–1.9732 |
|
| |||
| BCLC staging | |||
| • C–D | • 0.0102 | • 5.4179 | • 1.4936–19.6531 |
|
| |||
| Number of lesions | |||
| • <3 | • 0.6088 | • 1.3119 | • 0.4639–3.7099 |
|
| |||
| Maximum diameter | |||
| • ≥5 cm | • 0.2943 | • 2.0947 | • 0.5259–8.3432 |
HCV: Hepatitis C Virus, BCLC: Barcelona Clinic Liver Cancer.